Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
61,856.01 +2,810.86 (+4.76%) CMC Crypto 200
1,340.82 +63.85 (+5.00%)
Roche Holding AG (0TDF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 02:30PM BST
| Previous close | 29.31 |
| Open | 30.04 |
| Bid | 28.10 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 30.04 - 30.04 |
| 52-week range | 30.04 - 40.26 |
| Volume | |
| Avg. volume | 352 |
| Market cap | 2.046B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 0.15 |
| EPS (TTM) | 2.07 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.